MBBS (S’pore), MRCP (UK)
Lung cancers, especially non-smoking related lung cancers such as EGFR mutant cancers
Dr Chin is a specialist in Medical Oncology. She graduated from NUS in 1997, and completed her internal medicine and oncology training at NUH. She was awarded membership with the Royal College of Physicians in 2002, and specialist accreditation in medical oncology in 2005. She was subsequently awarded the HMDP fellowship and underwent further sub-specialization training in thoracic oncology with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre, USA in 2006-2007.
Prior to joining Raffles Cancer Centre, Dr Chin was practising as a senior consultant at the National University Cancer Institute at NUH, and visiting consultant at Ng Teng Fong Hospital. Her commitment to patient care has been recognized by Spring’s excellent service award. In addition, she contributes her expertise in thoracic oncology in various MOH committees, formulating guidelines on screening and treatment for lung cancers. She is also advisory member for lung cancer for Singapore Cancer Society. She was core faculty for the oncology senior residency program at NUHS.
Dr Chin’s area of interest is in lung cancers, especially non-smoking related lung cancers such as EGFR mutant cancers, in addition to general oncology. With a keen and active interest in translational and clinical research to better patient care, she has conducted numerous international industry sponsored and investigator initiated clinical trials as principal and co-investigator. She has received grants from the National Medical Research Council and RISE Grant Scheme Award. Her works have been published in peer-reviewed journals. Specifically, she has contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumor and blood. She is the Principle Associate at the Cancer Science Institute of Singapore. She is member of American Society of Clinical Oncology, American Association for Cancer Research and the International Association of Lung Cancer.